FindTrial
Sign In

Antimicrobial Treatment Strategies for Patients with MDRO Infections: A Multicenter Real-world Retrospective Study

Antimicrobial Treatment Strategies for Patients with MDRO Infections: A Multicenter Real-world Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091023
Enrollment
Unknown
Registered
2024-10-18
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious Disease

Interventions

Different medication regimens for anti MDRO infection:None

Sponsors

Nanjing Drum Tower Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult patients (age =18 years). Patients diagnosed with MDRO infections based on culture results. Patients treated with antimicrobials for MDRO infections. Patients admitted to the study hospital between January 2020 and June 2024. Patients with complete diagnostic and case information.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
14 day clinical response rate;—

Secondary

MeasureTime frame
14 Day microbiology eradication;Length of Hospital Stay;Test of cure;Readmission rate after 30 days;Adverse drug reactions;SIRS within first week after treatment;—

Countries

China

Contacts

Public ContactDayu Chen

Nanjing Drum Tower Hospital

cdy_pharmacy@njglyy.com+86 159 5191 6689

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026